Coherus Biosciences Inc (CHRS) is destined for greater heights as its last quarter sales were 70,770 K
Coherus Biosciences Inc (NASDAQ: CHRS) on Tuesday, plunged -5.04% from the previous trading day, before settling in for the closing price of $1.39. Within the